Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium: Potential Utility of Fosfomycin-Reference-Cited by-同舟云学术

Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium: Potential Utility of Fosfomycin

Published:2003-01 Issue:1 Volume:35 Page:12-14
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

SHRESTHA NABIN K.¹,CHUA JIMMY D.²,TUOHY MARION J.²,WILSON DEBORAH A.²,PROCOP GARY W.²,LONGWORTH DAVID L.¹,ISADA CARLOS M.¹,HALL GERRI S.²

Affiliation:

1. Department of Infectious Diseases The Cleveland Clinic Foundation Cleveland

2. Section of Clinical Microbiology The Cleveland Clinic Foundation Ohio Cleveland

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0036554021000026985

Reference11 articles.

1. Moellering RC Jr. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone; 2000. pp. 2147–56.

2. In-vitro activity of fosfomycin against vancomycin-resistant enterococci

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation of a Multidrug-Resistant vanA-Positive Enterococcus faecium Strain from a Canine Clinical Sample in Greece;Microbiology Research;2023-04-30

2. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India;Microbial Drug Resistance;2020-12-01

3. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management;Infection and Drug Resistance;2015-07

4. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?;Urology Annals;2015

5. Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2014-04-30